Moderate hypofractionated helical tomotherapy for older patients with localized prostate cancer: long-term outcomes of a phase I–II trial
By:
Authors
Di Cui
Medical School of Chinese PLA, Beijing, China
Department of Radiotherapy, Peking University International Hospital, Beijing, China
Lei Du
Department of Radiation Oncology, Hainan Hospital of the Chinese PLA General Hospital, Sanya, China
Wei Yu
Department of Radiation Oncology, First Medical Center of the Chinese PLA General Hospital, Beijing, China
Boning Cai
Department of Radiation Oncology, First Medical Center of the Chinese PLA General Hospital, Beijing, China
Lingling Meng
Department of Radiation Oncology, First Medical Center of the Chinese PLA General Hospital, Beijing, China
Jun Yang
Department of Radiation Oncology, Xinxiang Medical University First Affiliated Hospital, Xinxiang, China
Yanrong Luo
Department of Radiation Oncology, First Medical Center of the Chinese PLA General Hospital, Beijing, China
Jing Chen
Department of Radiation Oncology, First Medical Center of the Chinese PLA General Hospital, Beijing, China
Lin Ma
Medical School of Chinese PLA, Beijing, China
Department of Radiation Oncology, First Medical Center of the Chinese PLA General Hospital, Beijing, China
Language: English
Page range: 216 - 227
Submitted on: Aug 2, 2021
Accepted on: Feb 11, 2022
Published on: Mar 28, 2022
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Keywords:
Related subjects:
© 2022 Di Cui, Lei Du, Wei Yu, Boning Cai, Lingling Meng, Jun Yang, Yanrong Luo, Jing Chen, Lin Ma, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.